Early tracheostomy in acute heart failure exacerbation

Area of Science:

• Cardiology
• Pulmonology
• Health Services Research

Background:

• The optimal timing for tracheostomy in acute heart failure (AHF) exacerbation remains debated.
• Previous studies have explored the utility of early tracheostomy, but consensus is lacking.

Purpose of the Study:

• To assess the utilization trends of early tracheostomy in AHF exacerbation patients in the United States.
• To compare the clinical and economic outcomes of early versus late tracheostomy in this patient population.

Main Methods:

• Retrospective cohort study utilizing the National Inpatient Sample (2005-2014).
• Propensity score matching was employed to compare outcomes between early and late tracheostomy groups.
• Analysis included in-hospital mortality, total hospital cost, and length of stay.

Main Results:

• 0.26% of 1,390,356 AHF exacerbation admissions underwent tracheostomy; 19.4% of these were early.
• No significant shift in early tracheostomy utilization was observed from 2008-2014.
• Early tracheostomy was associated with significantly lower median total hospital costs ($53,466 vs. $73,680) and shorter lengths of stay (19 vs. 26 days) compared to late tracheostomy.

Conclusions:

• Early tracheostomy in AHF exacerbation patients demonstrates economic advantages, including reduced hospital costs and shorter lengths of stay.
• In-hospital mortality rates were comparable between early and late tracheostomy groups.
• These findings suggest that early tracheostomy can be a beneficial strategy for managing AHF exacerbation from an economic perspective.